Genfit S A (GNFT) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genfit S a   (NASDAQ: GNFT)


Genfit S A's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Genfit S A's ROI in the fourth quarter of 2024?
Genfit S a achieved a return on average invested assets (ROI) of 2.22 % in its fourth quarter of 2024, this is above GNFT's average return on investment of -18.6%.
Genfit S A invested over the 12 months ending in its fourth quarter of 2024 $76 million

ROI has improved compared to -42.06% in the third quarter of 2024, due to net income growth.

Within the Healthcare sector 191 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from to 2115.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM 0.25 % -7.12 % -15.17 % -21.99 % -27.85 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 72 78 78 78 75
Return On Investment (TTM) 2.22 % -42.06 % -42.26 % -42.45 % -42.65 %
GNFT's Overall Ranking # 2115 # # # # 4597
Seq. Investment Change TTM -1.14 % 0.47 % 0.47 % 0.47 % -8.41 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 2 -32 -32 -32 -32

GNFT Company Profile >> Back to GNFT Roi Comparisons >> See Annual GNFT Return On Investment



Return On Investment GNFT's Ranking
Within: No.
Industry # 19
Sector # 192
Overall # 2115

Return On Investment Statistics
High Average Low
31.93 %
-18.6 %
-61.38 %
(Dec 31 2021)   (Dec 31 2020)







Financial Statements
Genfit S A's IV. Quarter Investments $ 72 Millions GNFT's Balance sheet
Genfit S A's IV. Quarter Income $ 2 Millions Quarterly GNFT's Income Statement
GNFT's Income by Division See GNFT's Income by Division


GNFT Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 72 75 103 249 188
Y / Y Investment Growth -4.67 % -27.04 % -58.66 % 32.42 % -37.68 %
Net Income in Millions 2 -31 -25 80 -115
Y / Y Net Income Growth - - - - -
Annual Return On Investment 2.28 % -41.58 % -24.25 % 31.93 % -61.38 %


Annual Roi Comment
In the fiscal year 2024 ROI improved to 2.28 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GNFT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GNFT's Competitors
Subscribers only: Roi for Genfit S A's Suppliers
Subscribers only: Return On Investment for GNFT's Customers

Other Ratios
GNFT's Roa GNFT's Inventory Turnover Ratio GNFT's Growth Rates GNFT's Dividend Statistics
GNFT's Profitability Ratios GNFT's Asset Turnover Ratio GNFT's Dividend Growth
GNFT's Roe GNFT's Valuation Ratios GNFT's Financial Strength Ratios GNFT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI
Boston Scientific Corporation  6.05 %
Amgen Inc   6.00 %
Sanofi  5.87 %
Merit Medical Systems Inc  5.51 %
Fonar Corporation  5.47 %
Jazz Pharmaceuticals Plc  5.45 %
Medtronic Plc  5.40 %
Ensign Group Inc  5.38 %
Icon Plc  5.25 %
Labcorp Holdings Inc   5.25 %
Henry Schein Inc   5.20 %
Kamada Ltd   5.06 %
Precision Biosciences Inc  4.99 %
Acadia Healthcare Company Inc   4.98 %
Transmedics Group Inc   4.98 %
Zimmer Biomet Holdings Inc   4.92 %
Puretech Health Plc  4.82 %
Select Medical Holdings Corp  4.73 %
Brainsway Ltd   4.69 %
Steris Plc  4.59 %
Pfizer Inc  4.58 %
Docgo Inc   4.39 %
The Pennant Group Inc   4.37 %
Nature s Sunshine Products inc   4.31 %
U S Physical Therapy Inc  4.30 %
Stevanato Group S p a   4.20 %
Hutchmed china Limited  4.13 %
Solventum Corporation  4.00 %
Smith and Nephew Plc  3.98 %
Integer Holdings Corporation  3.93 %

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.